Related Experiment Video
Updated: Jan 13, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
87.5K
Negative Results in Neonatal Trials: Clinical Lessons and Future Directions - A Narrative Review
Ashraf Gad1,2, Ammar Yasser Nofal3, Leena Khalid Al-Qassem4
1Critical Care, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Biomedicine Hub
|January 12, 2026
Summary
Negative trial results in neonatal research are crucial for advancing evidence-based care. Properly interpreting these findings prevents unnecessary interventions and guides future studies, benefiting neonatal clinical practice and research development.
Area of Science:
- Neonatal clinical research
- Evidence-based medicine
Background:
- Clinical trials in neonates face ethical and practical challenges.
- Trial termination due to negative results contributes to publication bias.
- Failure to report unfavorable outcomes hinders medical knowledge advancement.
Purpose of the Study:
- To review the significance of negative trial results in neonatal research.
- To assess the reliability and interpretation challenges of negative findings.
- To explore the implications of negative outcomes for neonatal clinical practice.
Main Methods:
- Focused on interventional studies in neonatal clinical research.
- Excluded non-interventional studies to concentrate on controlled trials.
- Analyzed insights from selected negative neonatal trials.
Main Results:
- Negative trial results are valuable for avoiding unnecessary interventions.
- These findings optimize resource allocation in neonatal care.
- Unfavorable outcomes guide future research directions effectively.
Conclusions:
- Properly interpreted negative trials are fundamental to evidence-based neonatal care.
- Enhanced reporting and interpretation of negative findings benefit clinical practice.
- Valuing negative results accelerates research development in neonatology.
Related Concept Videos
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:28Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
395
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
395
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K